Skip to main content
. 2021 Mar 26;21(1):84–92. doi: 10.5230/jgc.2021.21.e9

Table 2. The 3-year and 5-year OS rates for each LNR group.

LNR stage LNR group No. of patients 3-year OS 5-year OS HR 95% CI
0 LNR = 0 364 89.3% 80.6% Ref.
1 0 < LNR ≤ 0.1 128 71.4% 63.0% 1.816 1.309–2.519
2 103
0.1 < LNR ≤ 0.2 49 49.2% 28.7% 4.420 3.005–6.502
0.2 < LNR ≤ 0.3 22 25.5% 12.7% 6.641 4.005–11.014
0.3 < LNR ≤ 0.4 7 41.7% 0% 8.866 3.216–24.441
0.4 < LNR ≤ 0.5 15 35.7% 19.0% 5.252 2.875–9.595
0.5 < LNR ≤ 0.6 10 40.5% 20.3% 6.307 2.735–14.546
3 10
0.6 < LNR ≤ 0.7 4 0% 0% 18.465 6.673–51.097
0.7 < LNR ≤ 0.8 2 0% 0% 21.250 5.112–88.335
0.8 < LNR ≤ 0.9 1 0% 0% 17.324 2.379–126.155
0.9 < LNR ≤ 1.0 3 0% 0% 33.186 10.194–108.037

LNR = lymph node ratio; OS = overall survival; HR = hazard ratio; CI = confidence interval.